For US residents only.
We’re committed to making treatment with KISQALI® (ribociclib) as affordable as possible. Read below to learn about ways you may be able to save on your KISQALI prescription, and then see how a KISQALI Care Patient Navigator can help simplify this process for you.
Patients are eligible to receive a 1-treatment cycle supply of any one of the following at no cost.*
a. KISQALI® (ribociclib)
b. FEMARA® (letrozole)
d. KISQALI + FEMARA
e. KISQALI + letrozole
f. KISQALI FEMARA Co-Pack
Call 1-800-282-7630 or visit www.FreeTreatmentVoucher.com to receive your free treatment voucher.
The KISQALI® (ribociclib) FEMARA® (letrozole) Co-Pack is a prescription medicine used as the first hormonal based therapy to treat women who have gone through menopause with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic).
The KISQALI FEMARA Co-Pack contains 2 different types of medicines:
• The violet tablet contains the medicine KISQALI® (ribociclib).
• The yellow tablet contains the medicine FEMARA® (letrozole).
*No purchase required of the KISQALI FEMARA Co-Pack, or KISQALI or FEMARA (including generic letrozole). This offer is available for patients with a valid prescription for the KISQALI FEMARA Co-Pack, or for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product.
Patients with commercial insurance who are still waiting for their coverage to take effect for the KISQALI FEMARA Co-Pack or KISQALI may be eligible for an additional supply of KISQALI that could continue for up to 5 treatment cycles.†
For more information, talk to your doctor or call 1-800-282-7630 to speak to one of our KISQALI Care Patient Navigators.
†Limitations apply. Eligible patients must have commercial insurance, a completed Service Request Form, and be experiencing a delay in obtaining coverage for KISQALI. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, Tricare, or any other federal or state program. No purchase necessary. Participation is not a guarantee of insurance coverage. Once coverage is approved, patients will no longer be eligible. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.
You may be eligible for immediate co-pay savings on your next KISQALI FEMARA Co-Pack, KISQALI and/or FEMARA (including generic letrozole) prescriptions:
‡Limitations apply. Patient must have commercial insurance. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit www.CoPay.NovartisOncology.com or call 1-877-577-7756.
See if you are eligible for the Universal Co-Pay Program at www.CoPay.NovartisOncology.com, or call 1-877-577-7756.
If you are covered by Medicaid, Medicare, or any other federal or state insurance program, your KISQALI Care Patient Navigator can help you understand your drug coverage and provide information about resources that may be able to provide financial assistance.
For information, call 1-800-282-7630.
Some people who are uninsured or underinsured may face difficulties when it comes to paying for their medicine. People who are uninsured do not have a health insurance plan. People who are underinsured do have some type of health insurance coverage, but have to pay high deductibles and/or out-of-pocket costs.
Novartis Oncology is committed to helping all patients get access to the medicines they need. If you are experiencing financial hardship, don't have insurance coverage, or your insurance coverage doesn't cover the full cost of your medicines, you may be eligible to receive your Novartis medicines at no cost.
To learn more, call 1-800-282-7680.
KISQALI Care is brought to you by Novartis Patient Assistance Now Oncology.